Skip to main content
SpringerLink
Log in

GH/IGF-I axis in anorexia nervosa

  • Review Article
  • Published:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Aims and scope Submit manuscript

Abstract

Patients with anorexia nervosa (AN) may develop multiple endocrine abnormalities, including amenorrhea, hyperactivity of the hypothalamus-pituitary-adrenal axis, hypothyroidism and particular changes in the activity of the growth hormone (GH)/insulin-like growth factor I (IGF-I) axis. Exaggerated GH secretion and reduced IGF-I levels are usually found in AN, as well as in conditions of malnutrition and malabsorption, insulin-dependent diabetes mellitus, liver cirrhosis and catabolic states. In AN, GH hypersecretion at least partially reflects malnutrition-induced peripheral GH resistance, which leads to reduced IGF-I synthesis and release; this implies an impairment of the negative IGF-I feedback action on GH secretion. On the other hand, primary alterations in the neural control of GH secretion cannot be ruled out. The neuroendocrine alterations include enhanced somatotroph responsiveness to growth hormone releasing hormone (GHRH) and impaired GH response to most central nervous system-mediated stimuli. Particular resistance to cholinergic manipulation has also been demonstrated, thus suggesting a somewhat specific alteration in the somatostatin (SS)-mediated cholinergic influence on GH secretion. Moreover, paradoxical GH responses to glucose load, thyrotropin releasing hormone (TRH) and luteinizing hormone releasing hormone (LHRH) have also been reported. The effect of reduced leptin levels on GH hypersecretion in AN is still unclear, but ghrelin (the gastric hormone that is a natural ligand of the GH secretagogue receptor and strongly stimulates somatotroph secretion) is thought to play a major role. Regardless of the supposed central and peripheral alterations, it has to be emphasised that the activity of the GH/IGF-I axis in AN is generally restored by nutritional and stable weight gain. It therefore reflects an impaired nutritional state and cannot be considered a primary hallmark of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Furlanetto R.W.: Insulin-like growth factor measurements in the evaluation of growth hormone secretion. Horm. Res., 33 (suppl. 4), 25–30, 1990.

    CAS  PubMed  Google Scholar 

  2. Casanueva F.F.: Physiology of growth hormone secretion and action. Endocrinol. Metab. Clin. North Am., 21, 483, 1992.

    CAS  PubMed  Google Scholar 

  3. Müller E.E, Nisticò G.: Neurotransmitter regulation of the anterior pituitary. In: Muller E.E., Nisticò G. (Eds.), Brain messengers and the pituitary. San Diego, Acadaemic Press, 1989, pp. 404–537.

    Google Scholar 

  4. Ghigo E.: Neurotransmitter control of growth hormone secretion. In: De la Cruz L.F. (Ed.), Regulation of growth hormone and somatic growth. Amsterdam, Elsevier Science Publishers, 1992, pp. 103–136.

    Google Scholar 

  5. Hartman M.L., Veldhuis J.D., Thorner M.O.: Normal control of growth hormone secretion. Horm. Res. 40, 37–47, 1993.

    CAS  PubMed  Google Scholar 

  6. Tannenbaum G.S.: Genesis of episodic growth hormone secretion. J. Pediatr. Endocrinol. Metab., 6, 273–282, 1993.

    CAS  Google Scholar 

  7. Kojima M., Hosada H., Data Y., Nakazato M., Matzuo H., Kankawa K.: Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature, 402, 656–660, 1999.

    CAS  PubMed  Google Scholar 

  8. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., Casanueva F., Deghenghi R., Camanni F., Ghigo E.: Endocrine activities of Ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with Hexarelin, a non natural peptydil GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 86, 1169–1174, 2001.

    CAS  PubMed  Google Scholar 

  9. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M.: Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425–432, 1994.

    CAS  PubMed  Google Scholar 

  10. Bauman G., Shaw M.A., Amburn K.: Circulating growth hormone binding proteins. J. Endocrinol. Invest., 17, 67–81, 1994.

    Google Scholar 

  11. Postel-Vinay M.C., Saab C., Gourmelen M.: Nutritional status and growth hormonebinding proteins. Horm. Res. 44, 177–181, 1995.

    CAS  PubMed  Google Scholar 

  12. Jones J., Clemmons D.R.: Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16, 3–34, 1995.

    CAS  PubMed  Google Scholar 

  13. Zapf J.: Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol., 132, 645–654, 1995.

    CAS  PubMed  Google Scholar 

  14. Davidson M.B.: Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev., 8, 115–131, 1987.

    CAS  PubMed  Google Scholar 

  15. Wabitsch M., Hauner H., Heinze E., Teller W.: In vitro effects of growth hormone in adipose tissue. Acta Paediatr., 406, 48–53, 1994.

    CAS  Google Scholar 

  16. De Feo P.P.: Hormonal regulation of human protein metabolism. Eur. J. Endocrinol., 135, 7–18, 1996.

    PubMed  Google Scholar 

  17. Florini J.R., Ewton D.Z., Coolican S.A.: Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev., 17, 481–517, 1996.

    CAS  PubMed  Google Scholar 

  18. Iranmanesh A., Lizzaralde G., Veldhuis J.D.: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab., 73, 1081–1088, 1991.

    CAS  PubMed  Google Scholar 

  19. Thissen J.P., Ketesleger J.M., Underwood L.E.: Nutritional regulation of insulin-likegrowth-factors. Endocr. Rev., 15, 80–85, 1994.

    CAS  PubMed  Google Scholar 

  20. Ghigo E., Arvat E., Gianotti L., Maccario M., Camanni F.: The regulation of growth hormone secretion. In: Jenkins R.C., Ross R.J.M. (Eds.), The endocrine response to acute illness. Front. Horm. Res. Basel, Karger, 1999, vol. 24, pp. 152–175.

    CAS  Google Scholar 

  21. Argente J., Caballo N., Barrios V., Munoz M.T., Pozo J., Chowen J.A., Morande G., Hernandez M.: Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short and longterm weight recuperation. J. Clin. Endocrinol. Metab., 82, 2084–2092, 1997.

    CAS  PubMed  Google Scholar 

  22. Stoving R.K., Veldhuis J.D., Flyvbjerg A., Vinten J., Hangaard J., Koldkjaer O.G., Kristiansen J., Hagen K.: Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J. Clin. Endocrinol. Metab., 81, 2056–2063, 1999.

    Google Scholar 

  23. Landon J., Greenwood F.C., Stamp T.C.B., Wynn V.: The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin, and comparison of this procedure with other tests of pituitary and adrenal function in patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J. Clin. Invest., 45, 437–449, 1966.

    CAS  PubMed Central  PubMed  Google Scholar 

  24. Mecklenburg R.S., Loriaux L., Thompson R.H., Andersen A.E., Lipsett M.B.: Hypothalamic dysfunction in patients with anorexia nervosa. Medicine, 53, 147–159, 1974.

    CAS  PubMed  Google Scholar 

  25. Brown G.M., Garfinkel P.E., Jeuniewic N., Moldofsky H., Stancer H.C.: Endocrine profiles in anorexia nervosa. In: Vigersky R. (Ed.), Anorexia nervosa. New York, Raven Press, 1977, pp. 123–135.

    Google Scholar 

  26. Halmi K.A.: Anorexia nervosa: recent investigation. Annu. Rev. Med., 29, 137–148, 1978.

    CAS  PubMed  Google Scholar 

  27. Dieguez C., Page M.D., Scanlon M.F.: Growth regulation and its alteration in disease states. Clin. Endocrinol., 28, 109–143, 1988.

    CAS  Google Scholar 

  28. Donaghy A.J., Baxter R.C.: Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. In: Ross R.J.M., Savage M.O. (Eds.), Bailliere’s Clin. Endocrinol. Metab., Growth hormone resistance. W.B. Saunders, London, 10, 421–447, 1996.

    CAS  Google Scholar 

  29. Argente J., Munoz M.T., Pozo J., Barrios V., Buno M., Chowen J.A., Hernandez M.: Growth hormone resistance in anorexia nervosa as a model of malnutrition. J. Endocrinol. Invest., 21, 24–28, 1998.

    Google Scholar 

  30. Counts D.R., Gwirtsman H., Carlsson L.M.S., Lesem M., Cutler G.B.: The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J. Clin. Endocrinol. Metab. 75, 762–767, 1992.

    CAS  PubMed  Google Scholar 

  31. Bentham J., Rodriguez-Arnao J., Ross R.J.M.: Acquired growth hormone resistance in patients with hypercatabolism. Horm. Res., 40, 87–91, 1993.

    CAS  PubMed  Google Scholar 

  32. Ross R.J.M., Chew S.L.: Acquired growth hormone resistance. Eur. J. Endocrinol., 132, 655–660, 1995.

    CAS  PubMed  Google Scholar 

  33. Veldhuis J.D., Carlson M.L., Johnson M.L.: The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc. Natl. Acad. Sci. USA, 84, 7686–7690, 1987.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Scacchi M., Pincelli A.I., Caumo A., Tomasi P., Delitalia G., Baldi G., Cavagnini F.: Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J. Clin. Endocrinol. Metab., 82, 3225–3229, 1997.

    CAS  PubMed  Google Scholar 

  35. Pirke K.M., Ficher M.M., Pahl J.: Noradrenaline, triiodothyronine, growth hormone and prolactin during weight gain in anorexia nervosa. Int. J. Eat. Dis., 4, 499–502, 1985.

    Google Scholar 

  36. Vigersky R.A., Loriaux D.L.: Anorexia nervosa as a model of hypothalamic dysfunction. In: Vigersky R.A. (Ed.), Anorexia nervosa. New York, Raven Press, 1977, pp. 109–121.

    Google Scholar 

  37. Nussbaum M.P.: Anorexia nervosa. In: McArney M.D. (Ed.), Textbook of adolescent medicine. Philadelphia, Saunders W.B., 1992, p. 536.

    Google Scholar 

  38. Aro A., Lamberg B.A., Pelkonen R.: Hypothalamic endocrine dysfunction in anorexia nervosa. Acta Endocrinol., 5, 673–678, 1977.

    Google Scholar 

  39. Gianotti L., Pincelli A.I., Scacchi M., Rolla M., Bellitti D., Arvat E., Lanfranco F., Torsello A., Ghigo E., Cavagnini F., Müller E.E.: Effects of recombinant human insulinlike growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone stimulated GH secretion in anorexia nervosa. J. Clin. Endocrinol. Metab., 85, 2805–2809, 2000.

    CAS  PubMed  Google Scholar 

  40. Shibasaki T., Hotta M., Masuda A. et al.: Plasma GH response to GHRH and insulin hypoglycemia in man. J. Clin. Endocrinol. Metab., 60, 1265–1267, 1985.

    CAS  PubMed  Google Scholar 

  41. Roth J., Glick S.M., Yalow R.S., Berson S.A.: Secretion of human growth hormone: Physiologic and experimental modification. Metabolism, 58, 577–581, 1963.

    Google Scholar 

  42. Schreiber W., Schweiger V., Werbiner D., Brumer G., Tuschl R.J., Laessle R.G., Krieg J.C., Fichter M.M., Pirke K.M.: Circadian pattern of large neutral aminoacids, glucose, insulin and food intake in anorexia nervosa and bulimia nervosa. Metabolism 40, 503–507, 1991.

    CAS  PubMed  Google Scholar 

  43. Knopf R.F., Conn J.W., Fajans S.S., Floyd J.C., Guntsche E.M., Rull J.A.: Plasma growth hormone response to intravenous administration of amino acids. J. Clin. Endocrinol. Metab., 25, 1140–1144, 1965.

    CAS  PubMed  Google Scholar 

  44. Merimee T.J., Rabinowitz D., Fineberg S.E.: Arginine-initiated release of human growth hormone. N. Engl. J. Med., 26, 1434–1439, 1969.

    Google Scholar 

  45. Kuhara T., Ikeda S., Ohned A., Sasaki Y.: Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. Am. J. Physiol., 260, E21–E26, 1991.

    CAS  PubMed  Google Scholar 

  46. Suematsu D., Ishikawa H., Kuboki T., Ito T.: Statistical studies on anorexia nervosa in Japan: detailed clinical data on 1011 patients. Psycother. Psychosom., 43, 96–103, 1985.

    CAS  Google Scholar 

  47. Sodeman, Sodeman: Pathologic physiology. Mechanism of disease. Philadelphia, W.B. Saunders Company, 1974, pp. 846–863.

    Google Scholar 

  48. Podolsky S., Sivaprasad R.: Assessment of growth hormone reserve: comparison of intravenous arginine and subcutaneus glucagone stimulation test. J. Clin. Endocrinol. Metab., 35, 580–584, 1972.

    CAS  PubMed  Google Scholar 

  49. Casper R.C., Davis J.M., Padney G.N.: The effect of the nutritional status and weight changes on hypothalamic functional tests in anorexia nervosa. In: Vigersky R. (Ed.), Anorexia Nervosa. New York, Raven Press, 1977, pp. 137–147.

    Google Scholar 

  50. Brambilla F., Ferrari E., Cavagnini F., Invitti C., Zanoboni A., Massironi R., Catalano M., Cocchi D., Müller E.E.: Alpha 2-adrenoreceptor sensitivity in anorexia nervosa: growth hormone response to clonidine or growth hormone releasing hormone stimulation. Biol. Psychiatry, 25, 256–264, 1989.

    CAS  PubMed  Google Scholar 

  51. Sizonenko P.C., Rabinovitch A., Schneider P., Paunier L., Wollheim C.B., Zahnd G.: Plasma growth hormone, insulin and glucagone responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth deficiency, panhypopituitarism and anorexia nervosa. Pediatr. Res., 9, 733–738, 1975.

    CAS  PubMed  Google Scholar 

  52. Hoffman D.M., Nguyen T.V., O’ Sullivan A.J., Baxter R.C., Ho K.K.: ITT and IGF-I in the diagnosis of growth hormone deficiency in adults. Lancet 27, 613–614, 1994.

    Google Scholar 

  53. Frankel R.J., Jenkins J.S.: Hypothalamic pituitary function in anorexia nervosa. Acta Endocrinol. (Copenh), 78, 209–213, 1975.

    CAS  Google Scholar 

  54. Blicke J.F., Reville P., Stephan F., Meyer P., Demangeat C., Sapin R.: The role of insulin, glucagone and growth hormone in the regulation of plasma glucose and free fatty acid levels in anorexia nervosa. Horm. Metab. Res., 16, 336–340, 1984.

    Google Scholar 

  55. Naka Y., Koh T., Kimoshita F.: The prolactin, growth hormone and cortisol response to insulin-induced hypoglycemia in anorexia nervosa. Int. J. Eating Disord., 6, 357–362, 1987.

    Google Scholar 

  56. Brauman H., Gregoire F.: The growth hormone response to insulin induced hypoglycaemia in anorexia nervosa and control underweight subjects. Eur. J. Clin. Invest., 5, 289–295, 1975.

    CAS  PubMed  Google Scholar 

  57. Casper R.C., Pandey G., Jaspan J.B., Rubenstein A.H.: Eating attitudes and glucose tolerance in anorexia nervosa patients at 8-year follow-up compared to control subjects. Psychiatry Res., 25, 283–299, 1988.

    CAS  PubMed  Google Scholar 

  58. Tamai H.T., Kiyohara K., Mukuta T., Kobayashi N., Komaki G., Nakagawa T., Kumagai L.F., Aoki T.T.: Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosa. Metabolism, 40, 31–34, 1991.

    CAS  PubMed  Google Scholar 

  59. Mercado M., Baumann G.: Characteristics of the somatotropic axis in insulin dependent diabetes mellitus. Arch. Med. Res., 26, 101–109, 1995.

    CAS  PubMed  Google Scholar 

  60. Maeda K., Kato Y., Yamaguchi N.: Growth hormone release following thyrotropinreleasing hormone injection into patients with anorexia nervosa. Acta Endocrinol., 81, 1–8, 1976.

    CAS  PubMed  Google Scholar 

  61. Maeda K., Tanimoto K., Chihara K.: Abnormal growth hormone release following luteinizing hormone releasing hormone in anorexia nervosa. Jpn. J. Psych. Neurol., 41, 41–45, 1987.

    CAS  Google Scholar 

  62. Kiriike N., Nishiwaki S., Izumiya Y., Maeda K., Kawakita Y.: Thyrotropin, prolactin and growth hormone response to intravenous administration of aminoacids. J. Clin. Endocrinol. Metab., 22, 167–171, 1987.

    CAS  Google Scholar 

  63. Valcavi R., Zini M., Portioli I.: Triiodotyronine administration reduces serum growth hormone levels and growth responses to thyrotropin-releasing hormone in patients with anorexia nervosa. Psyconeuroendocrinology, 15, 287, 1990.

    CAS  Google Scholar 

  64. Rolla M., Andreoni A., Bellitti D., Ferdeghini M., Ghigo E., Müller E.E.: Corticotrophinreleasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but is effective in patients with eating disorders. J. Endocrinol., 140, 327–332, 1994.

    CAS  PubMed  Google Scholar 

  65. Masuda A., Shibasaki T., Hotta M., Suematsu K., Shizume K.: Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin C level in the abnormal GH secretion. J. Endocrinol. Invest., 11, 297–301, 1988.

    CAS  PubMed  Google Scholar 

  66. Tamai H.T., Komaki G., Matsubayashi S., Kobayashi N., Mori K., Nakagawa T., Truong M.P., Walter R.M. Jr., Kumagai L.F.: Effect of cholinergic muscarinic receptor blockade on human growth factor (GH)releasing hormone-(1-44)-induced-GH secretion in anorexia nervosa. J. Clin. Endocrinol. Metab., 70, 738–741, 1990.

    CAS  PubMed  Google Scholar 

  67. Rolla M., Andreoni A., Belliti D., Cristofani R., Federghini M., Müller E.E.: Blockade of cholinergic muscarinic receptors by pyrenzepine and GHRH-induced GH secretion in the acute recovery phase of anorexia nervosa and atypical eating disorders. Biol. Psychiatry, 29, 1079–1086, 1991.

    CAS  PubMed  Google Scholar 

  68. Gianotti L., Arvat E., Valetto M.R., Ramunni J., Di Vito L., Maccagno B., Camanni F., Ghigo E.: Effects of beta-adrenergic agonists and antagonists on the GH response to GHRH in anorexia nervosa. Biol. Psychiatry 43, 181–187, 1998.

    CAS  PubMed  Google Scholar 

  69. Gianotti L., Fassino S., Abbate Daga G., Lanfranco F., De Bacco C., Ramunni J., Arvat E., Maccario M., Ghigo E.: Effects of free fatty acids and acipimox, a lypolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. Clin. Endocrinol., 52, 713–720, 2000.

    CAS  Google Scholar 

  70. Ghigo E., Arvat E., Gianotti L., Nicolosi M., Valetto M.R., Avagnina S., Bellitti D., Rolla M., Müller E.E., Camanni F.: Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol. Psychiatry, 36, 689–695, 1994.

    CAS  PubMed  Google Scholar 

  71. Rolla M., Andreoni A., Belliti D., Ferdeghini M., Ferrannini E.: Failure of glucose to suppress GH response to GHRH in patients with anorexia nervosa. Biol. Psychiatry, 27, 215–222, 1990.

    CAS  PubMed  Google Scholar 

  72. Gianotti L., Rolla M., Arvat E., Belliti D., Valetto M.R., Ferdeghini M., Ghigo E., Müller E.E.: Effect of somatostatin infusion on the somatotrope responsiviness to growth hormone-releasing hormone in patients with anorexia nervosa. Biol. Psychiatry, 43, 334–349, 1999.

    Google Scholar 

  73. Angelin B., Rudling M.: Growth hormone and hepatic lipoprotein metabolism. Curr. Opin. Lipidol., 5, 160–165, 1994.

    CAS  PubMed  Google Scholar 

  74. Marcus C., Margery V., Kamel A., Bronnegard M.: Effects of growth hormone on lipolysis in humans. Acta Pediatr., 406, 54–59, 1994.

    CAS  Google Scholar 

  75. Ghigo E., Arvat E., Broglio F., Giordano R., Gianotti L., Muccioli G., Papotti M., Graziani A., Bisi G., Deghenghi R., Camanni F.: Endocrine and non-endocrine activities of growth hormone segretagogues in humans. Horm. Res., (suppl 3), 9–15, 1999.

    Google Scholar 

  76. Bowers C.Y.: Unnatural growth hormonereleasing peptide begets natural Ghrelin. J. Clin. Endocrinol. Metab., 86, 1464–1469, 2001.

    CAS  PubMed  Google Scholar 

  77. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Nijima A., Fujino M.A., Kasuga M.: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology, 120, 337–345, 2001.

    CAS  PubMed  Google Scholar 

  78. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Hayashi Y., Kangawa K.: Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, 111483–111487, 2001.

    Google Scholar 

  79. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S.: A role for ghrelin in the central regulation of feeding. Nature, 409, 194–198, 2001.

    CAS  PubMed  Google Scholar 

  80. Tschop M., Weyer C., Tatarrani P.A., Devanarayan V., Ravussin E., Heiman M.L.: Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707–709, 2001.

    CAS  PubMed  Google Scholar 

  81. Giusti M., Foppiani L., Ponzani P., Cuttica C.M., Falivene M.R., Valenti S.: Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. J. Endocrinol. Invest., 20, 257–263, 1997.

    CAS  PubMed  Google Scholar 

  82. Popovic V., Micic D., Damjanovic S., Obradovic S., Djurovic M., Petakov M., Grudic D., Golubicic I., Nikitovic M., Mitrovic N., Dieguez C., Casanueva F.F.: Growth hormone segretagogues in pathological states: diagnostic implications. Acta Paediatr. (Suppl.), 423, 97–101, 1997.

    CAS  Google Scholar 

  83. Shintani M., Ogawa J., Ebihara K., AizawaAbe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., Nakao K.: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic that antagonizes leptin action through the activation of hypothalamic neurone Y/Y1 receptor pathway. Diabetes, 50, 227–232, 2001.

    CAS  PubMed  Google Scholar 

  84. Argente J., Caballo N., Barrios V., Munoz M.T., Pozo J., Chowen J.A., Hernandez M.: Disturbances in the growth hormone-insulin like growth factor axis in children and adolecents with different eating disorders. Horm. Res., 48 (Suppl 4), 16–18, 1997.

    CAS  PubMed  Google Scholar 

  85. Müller E.E., Rolla M., Ghigo E., Belliti D., Arvat E., Andreoni A., Torsello A., Locatelli V., Camanni F.: Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications. Drugs, 50, 805–837, 1995.

    PubMed  Google Scholar 

  86. Gerner R.H., Yamada T.: Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res., 238, 298–302, 1982.

    CAS  PubMed  Google Scholar 

  87. Kaye W.H., Rubinow D., Gwirtsman H.E., George D.T., Jimerson D.C., Gold P.W.: CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamicpituitary-adrenal cortical axis. Psychoneuroendocrinology, 13, 265–272, 1988.

    CAS  PubMed  Google Scholar 

  88. Arce V.M., Cella S.G., Locatelli V., Müller E.E.: Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin releasing hormone. Neuroendocrinology, 53, 467–472, 1991.

    CAS  PubMed  Google Scholar 

  89. Thomas G.B., Cumminis J.T., Francis H., Sudbury A.W., Mc Cloud P.I., Clarke I.J.: Effect of restricted feeding on the relationship between hypophyseal portal concentrations of growth hormone (GH)-releasing factor and somatostatin and jugular concentrations of GH in ovariectomized ewes. Endocrinology, 128, 1151–1158, 1991.

    CAS  PubMed  Google Scholar 

  90. De Marinis L., Mancini A., Valle D., Bianchi A., Gentilella R., Milardi D., Mascadri C., Giustina A.: Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa. Metabolism, 49, 155–159, 2000.

    PubMed  Google Scholar 

  91. Tannenbaum G.S., Painson J.C., Lengyel A.M., Brazeau P.: Paradoxical enhancement of pituitary growth hormone (GH) respon siveness to GH-releasing factor in the face of high somatostatin tone. Endocrinology, 124, 1380–1388, 1989.

    CAS  PubMed  Google Scholar 

  92. Massara F., Ghigo E., Goffi S., Molinatti G.M., Müller E.E., Camanni F.: Blockade of hpGRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab., 59, 1025–1026, 1984.

    CAS  PubMed  Google Scholar 

  93. Stoving R.K., Hangaard J., Habsen-Nord M., Hagen C.: A review of endocrine changes in anorexia nervosa. J. Pediatr. Res., 33, 139–152, 1999.

    CAS  Google Scholar 

  94. Kaye W.H., Ebert M.H., Lake R.C.: Central nervous system amine metabolism in anorexia nervosa. Presented at the 133rd Annual Meeting of the American Psychiatric Association, San Francisco, 1980.

    Google Scholar 

  95. Bellone J., Ghigo E., Procopio M., Arvat E., Valente F., Boffano GM., Maccario M., Dentelli P., Camanni F.: Comparison of the potentiating effect of pyridostigmine, arginine and propanolol on the GHRH induced GH release in short children. Panminerva Med., 35, 1–4, 1993.

    CAS  PubMed  Google Scholar 

  96. Grinspoon S., Gulick T., Askari H., Landt M., Lee K., Anderson E., Ma Z., Vignati L., Bowsher R., Herzog D., Klibanski A.: Serum leptin levels in women with anorexia nervosa. J. Clin. Endocrinol. Metab., 81, 3861–3863, 1996.

    CAS  PubMed  Google Scholar 

  97. Eckert E.D., Pomeroy C., Raymond N., Kohler P.F., Thuras P., Bowers C.Y.: Leptin in anorexia nervosa. J. Clin. Endocrinol. Metab., 83, 791–795, 1998.

    CAS  PubMed  Google Scholar 

  98. Haluzik M., Papezova M., Nedvidkova J., Kabrt J.: Serum leptin levels in patients with anorexia nervosa before and after partial refeeding: relationships to serum lipids and biochemical nutritional parameters. Physiol. Res., 48, 197–202, 1999.

    CAS  PubMed  Google Scholar 

  99. Pombo M., Pombo C.M., Astorga R., Cordido F., Popovic V., Garcia-Mayor R.V., Dieguez C., Casanueva F.F.: Regulation of growth hormone secretion by signals produced by the adipose tissue. J. Endocrinol. Invest., 22, 22–26, 1999.

    CAS  PubMed  Google Scholar 

  100. Friedman J.M., Halaas J.L.: Leptin and the regulation of body weight in animals. Nature 395, 763–770, 1998.

    CAS  PubMed  Google Scholar 

  101. Schwartz M.W., Woods S.C., Porte D.J., Seeley R.J., Bskin D.J.: Central nervous system control of food intake. Nature, 404, 661–671, 2000.

    CAS  PubMed  Google Scholar 

  102. Delvenne V., Goldman S., De Maertelaer V., Simon Y., Luxen A., Lotsra F.: Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain. Biol. Psychiatry, 40, 761–768, 1996.

    CAS  PubMed  Google Scholar 

  103. Delvenne V., Goldman S., De Maertelaer V., Lotsra F.: Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int. J. Eating Disord., 25, 29–37, 1999.

    CAS  Google Scholar 

  104. Ho KY., Veldhuis JD., Johnson ML., Furlanetto R.: Fasting enhances growth hormone secretion and amplifies the com plex rhythms of growth hormone secretion in man. J. Clin. Invest. 198, 968–975.

  105. Herington A.C.: Growth hormone receptor and binding protein: distribution and function. J. Pediatr. Endocrinol. 6, 235–240, 1993.

    CAS  PubMed  Google Scholar 

  106. Strobl J.S., Thomas M.J.: Human growth hormone: Pharmacol. Rev., 46, 1–34, 1994.

    CAS  PubMed  Google Scholar 

  107. Hochberg Z., Hertz P., Colin V., Ish-Shalom S., Yeshurun D., Youdim MB., Amit T.: The distal axis of growth hormone (GH) in nutritional disorders: GH binding protein, insulin-like growth factor-I (IGF 1), and IGF-1 receptors in obesity and anorexia nervosa. Metabolism, 41, 106–112, 1992.

    CAS  PubMed  Google Scholar 

  108. Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L., Hintz R.L.: Somatomedin C effects on both the hypothalamus and the pituitary. Science, 212, 1279–1288, 1981.

    CAS  PubMed  Google Scholar 

  109. Ceda G.P.: IGFs in the feedback control of GH secretion: hypothalamic and/or pituitary action? J. Endocrinol. Invest., 18, 734–737, 1995.

    CAS  PubMed  Google Scholar 

  110. Sato M., Frohman L.A.: Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology, 133, 793–799, 1993.

    CAS  PubMed  Google Scholar 

  111. Sjögren K., Liu J., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Törnell J., Isaksson O.G.P., Jansson J.O., Ohlsson C.: Liver-derived insulin-like growth factor I (IGF I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA, 96, 7088–7092, 1999.

    PubMed Central  PubMed  Google Scholar 

  112. Gianotti L., Broglio F., Arvat E., Pittoni G., Gallioli G., Zanello M., Colombo S., Marani F., Picarone M., Minuto F., Papini M.G., Boghen M.F., Miola C., Ghigo E.: GH/IGF I axis in catabolic patients with sepsis or trauma. The 79th Annual Meeting of the Endocrine Society, Minneapolis, June 11–14, 1997.

    Google Scholar 

  113. Uderwood L.E., Clemmons D.R., Maes M., D’Ercole A.J., Keteslegers J.M.: Regulation of somatomedin-C/insulin-like growth fac tor I by nutrients. Horm. Res., 24, 166–176, 1986.

    Google Scholar 

  114. Conover C.A., Lee P.D.K., Kanaley J.A., Clarkson J.T., Jensen M.D.: Insulin regulation of insulin-like growth factor binding protein-1 in obese and non obese humans. J. Clin. Endocrinol. Metab., 74: 1355–1360, 1992.

    CAS  PubMed  Google Scholar 

  115. Melmed S.: Insulin suppresses growth hormone secretion by rat pituitary cells. J. Clin. Invest. 73, 1425–1433, 1984.

    CAS  PubMed Central  PubMed  Google Scholar 

  116. Yamashita S., Melmed S.: Insulin regulation of rat growth hormone gene transcription. J. Clin. Invest. 78, 1008–1014, 1986.

    CAS  PubMed Central  PubMed  Google Scholar 

  117. Fukuda L, Hotta M., Hizuka N., Takano K., Ishikawa Y., Asakawa-Yasumoto K., Tagami E., Demura H.: Decreased serum levels of acid-labile subunit in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 84, 2034–2036, 1999.

    CAS  PubMed  Google Scholar 

  118. Hotta M., Fukuda I., Sato K., Hizuka N., Shibasaki T., Takano K.: The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 200–206, 2000.

    Google Scholar 

  119. Scanlon M.F., Issa B.G., Dieguez C.: Regulation of growth hormone secretion. Neuroendocrinology, 46, 149–154, 1996.

    CAS  Google Scholar 

  120. Nagakawa K., Matsubara M., Obara T., Kubo M., Akikawa K.: Responses of pituitary and adrenal medulla to insulin induced hypoglycaemia in patients with anorexia nervosa. Endocrinol. Jpn., 32, 719–724, 1985.

    Google Scholar 

  121. Assaad S.N., Cunningham G.R., Samaan N.A.: Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease. Metabolism 39, 349–356, 1990.

    CAS  PubMed  Google Scholar 

  122. Favaro A., Caregaro L., Burlina AB., Santonastaso P.: Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa. Psychosom. Med., 2000, 62, 535–538.

    CAS  PubMed  Google Scholar 

  123. Alvarez C.V., Mallo F., Burguera B., Cacicedo L., Dieguez C., Casanueva F.F.: Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone response to growth hormone-releasing hormone in the rat. Neuroendocrinology, 53, 185–189, 1991.

    CAS  PubMed  Google Scholar 

  124. Steppan C.M., Bailey S.T., Bhat S., Brown EJ., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A.: The hormone resistin links obesity to diabetes. Nature, 18, 292–293, 2001.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Internal Medicine, University of Turin, Italy

    L. Gianotti MD, F. Lanfranco, J. Ramunni, S. Destefanis, E. Ghigo & E. Arvat

Authors
  1. L. Gianotti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Lanfranco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Ramunni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Destefanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Ghigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Arvat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Gianotti MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gianotti, L., Lanfranco, F., Ramunni, J. et al. GH/IGF-I axis in anorexia nervosa. Eat Weight Disord 7, 94–105 (2002). https://doi.org/10.1007/BF03354435

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03354435

Key words

Search

Navigation